Log In or Register to Join The Conversation!
Viewing 15 reply threads
  • Author
    Posts
    • #18869
      Ally
      Keymaster

      We cover a lot of new research on the website ParkinsonsNewsToday.com but I’m curious to know – what are some Parkinson’s research projects you’re most excited about? Why? Feel free to share links in the comments to news stories if you have them!

    • #18879
      fakhiuddin ahmed
      Participant

      I want to have access to the studies underway, including stem cell transplantation, inducement of patients own stem cells to grow faster, invivo or exvivo, exchange of csf etc.

      Thanks

      f.ahmed md

    • #18882
      Andrew L.
      Participant

      Dopamine boost directly into brain via inactivated virus. Immune modulated response attacking harmful brain protein accumulation. Effects of light and sound therapy on brain. Not exactly excited (more interested) but trying to stay positive.

    • #18884
      Andrew L.
      Participant

      deleted coment

      • This reply was modified 8 months ago by Andrew L..
    • #18906
      Bob Hodgson
      Participant
    • #18943
      Andrew L.
      Participant

      Thanks for sharing that Bob! Plan to  get another scientific opinion on this…

    • #18959
      Charles H Levin
      Participant

      I was also going to post about the UCSD study (posted above by Bob Hodgson) that popped up last week on numerous health news feeds … This does appear to be very exciting news in that the researchers accidentally got mice to regenerate dopamine-producing neuron cells … all the mice recovered from their PD symptoms which never came back for the duration of their lives … When you think about the science of Parkinson’s as we know it, this might be groundbreaking …

      I exchanged emails with the co-author, Dr. William Mobley. I asked how long before they can start clinical trials. He said “years.”

      I would love to hear from anyone who knows more about the research trial process, the different phases and the kinds of hurdles involved, financial and regulatory that are involved.

    • #18961
      Andrew L.
      Participant

      Was also very excited by the study, but “years” is a bit depressing. I guess there are different stages of clinical trials, and it has to go through at least 4 before being approved.Maybe they can fast track it….

    • #18962
      Michael R. Scott
      Participant

      Bob,

      Thanks for bringing this new study.

      I’d read it and was going to post it here, but you beat me to it!… This could be a really BIG deal!… 🙂

    • #19123
      Bill Church
      Participant

      Good morning all….I have recently joined this forum and would like to make a general comment about PD research.  I have been studying and teaching about the chemical causes of PD for over 30 years.  It breaks my heart to read posts like the above where patients get their hopes up when new dopamine replacement research is published.  Please review these types of studies with one very important caveat:  The animal models used in these studies (the UCSD one cited above included) utilize an acute DA-depletion model – 6OHDA or MPTP – where the toxin that killed the DA cells initially is completely absent from the brain when the new cells are introduced (either into the Substantia nigra or the Striatum).  PD in humans is associated with a progressive, CHRONIC loss of dopamine cells, meaning that something has been killing these cells for many years (often decades).  The toxic environment responsible for contributing to the cell death still exists and if you put new DA-producing cells into this environment they will most likely die also….It’s like adding more logs to the firepit, the fire gets intense for a little bit, but the fire is still there and the logs will burn away.

    • #19281
      Jennifer Blackstone
      Participant

      Bill,Thank you for your comments about PD research.So many articles look promising but are usually years away or never  pan out.

      What do you think is the most promising area being tested now?  What do you think about the August 31 article about CDNF?

    • #19306
      Bill Church
      Participant

      @Jennifer Blackstone…I think that neurotrophic factors (CDNF and GDNF) are key in managing the chemical reactions involved in neurodegeneration.

       

      • #19976
        Christina
        Participant

        Hi Bill, Can you please elaborate on this or provide links?  frontiersin.org has an article on this but it is not in laymen terms.

    • #20012
      Andrew L.
      Participant

       

      Watch from 4 minutes on, reminds me of “awakenings”

       

      Doesn’t address what Bill is talking about tho….

    • #20014
      Andrew L.
      Participant

      Exercise apparently  helps in Parkinson’s by increasing the release of neurotrophic factors as mentioned above….making exercise a key component to the puzzle.   One problem apparently is that every time the research scientists come up with an important basic science research modification, it takes years for the new information to translate clinically as new clinical trials are needed. So if you are a few years into a clinical trial and then find something better, you just can’t switch it out…. Bottom line is there can be a huge lag (as in multiple years) between the basic science research breakthroughs and the actual clinical applications.  Finally, COVID slowed everything to a near halt making 2020 essentially a lost year.  Sorry if that is too negative, I have PD but also think it is important to keep it real…

    • #20015
      Charles H Levin
      Participant

      I was recently tested for genetic mutations to see if I carry the lrrk2 gene; I do. This now means I’m eligible to be part of a study by Denali Therapeutics that seeks to repair that genetic defect (at least that’s how I understood my doctor’s explanation).

      I’m still unclear about other details as are the people at Cedars Sinai in LA who I’m working with … No one seems to know if what phase this will be and when it will start. The study coordinator at Cedars was confident that my doc’s patients who qualify will be entered into the study ….

      Eligibility criteria are a PD Diagnosis, LRRK2 gene and Ashkenazi Jewish descent …

      If anyone else has more details on this, I would appreciate hearing from you …

    • #20020
      Randy S.
      Participant

       

      Awesome link summariing all active trials related to disease modifying therapies and symptomatic therapy

       

      https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&p=PMC3&id=7458531_jpd-10-jpd202128-g003.jpg

Viewing 15 reply threads
  • You must be logged in to reply to this topic.
Copyright © 2017-2021 All rights reserved.

©2021 KLEO Template a premium and multipurpose theme from Seventh Queen

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending
or

Log in with your credentials

or    

Forgot your details?

or

Create Account